It is a double-blind, placebo-controlled Phase 2 study enrolling 120 participants
This peptide has gained attention in the sports community due to its potential ability to enhance endurance, improve muscle tone, and accelerate post-exercise recovery
Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker
10.1016/j.bbr.2020.112919 Summary Keywords retina, ischemia, BPC 157, L-NAME, rats Citation Zlatar M, Kokot A, Vuletic LB, Masnec S, Kralj T, Perisa MM, Barisic I, Radic B, Milanovic K, Drmic D, Seiwerth S and Sikiric P (2021) BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats
Clinical Applications: